Maternal iron supplementation reduced risk for low birth weight in low- and middle-income countries but did not affect risk for preterm birth.
Given that anemia affects 38% of pregnant women worldwide, prenatal iron supplements are commonly recommended. Observational studies have shown that antenatal anemia is associated with excess risk for preterm birth. However, evidence supporting the effects of prenatal iron supplementation on neonatal outcomes has been mixed. Investigators conducted a meta-analysis of 48 randomized trials of iron supplementation (collectively involving 17,793 women) and 44 cohort studies of maternal anemia and birth outcomes (involving almost 2 million women).
In the randomized trials, iron supplementation was associated with a significant reduction in risk for low birth weight (relative risk, 0.81; 95% confidence interval, 0.71 to 0.93); however, it did not …
Reviewing Author
DisclosuresConsultant/Advisory BoardPlanned Parenthood Federation of America
Grant/Research SupportSociety of Family Planning; California Department of Public Health Tobacco Control Program
Editorial BoardsContraception; Journal of General Internal Medicine
Leadership Positions in Professional SocietiesCouncil Member, Society of General Internal Medicine
DisclosuresConsultant/Advisory BoardPlanned Parenthood Federation of America
Grant/Research SupportSociety of Family Planning; California Department of Public Health Tobacco Control Program
Editorial BoardsContraception; Journal of General Internal Medicine
Leadership Positions in Professional SocietiesCouncil Member, Society of General Internal Medicine